Application 761379

Type
BLA
Sponsor
FRESENIUS KABI USA

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761379Otulfiustekinumab-aauz351(k) InterchangeableRx2026-09-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OTULFIUSTEKINUMAB-AAUZINJECTABLE;INJECTION45MG/0.5MLNoNo
002OTULFIUSTEKINUMAB-AAUZINJECTABLE;INJECTION90MG/1MLNoNo
003OTULFIUSTEKINUMAB-AAUZINJECTABLE;INJECTION130MG/26MLNoNo

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84811SUPPL 2026-01-21
84810SUPPL 2026-01-21
84778SUPPL 2026-01-20
83114SUPPL 2025-08-18
83113SUPPL 2025-08-18
83112SUPPL 2025-08-18
83104SUPPL 2025-08-18
82482ORIG 2025-06-09
82167ORIG 2025-05-08
82157ORIG 2025-05-05
82139SUPPL 2025-05-05
82271SUPPL 2025-04-30
82269ORIG 2025-04-30
82006SUPPL 2025-04-25
81949SUPPL 2025-04-21
81776SUPPL 2025-03-28
81722SUPPL 2025-03-25
81306SUPPL 2025-02-21
81297SUPPL 2025-02-20
79775ORIG 2024-09-30
79761ORIG 2024-09-30